Nymox Pharmaceutical Corp
NYMXF- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001018735
No open-market purchases or sales by Nymox Pharmaceutical Corp insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4.21K in total; no superinvestor holds it.
Politicians who traded NYMXF
Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.
- Trades
- 1
- Filings
- 1
- Politicians
- 1
- Buys / sells
- 0 / 1
- Estimated volume
- $75.0K
- Sum of range midpoints
| Politician | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
 Gregory F. Murphy House · NC | 1 | 0 / 1 | $75.0K | Jan 22, 2021 | Feb 12, 2021 |
Trades
Reported trades in Nymox Pharmaceutical Corp, newest filings first.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.